Table 2.
Durable Viral Load Suppression, a New York City Department of Health and Mental Hygiene Sexual Health Clinic and Hospital Detoxification Patients, N = 99
| TOTAL | 12-Month Follow-Up | Test Statistic | p b | 18-Month Follow-Up | Test Statistic | p b | |||
|---|---|---|---|---|---|---|---|---|---|
|
| |||||||||
| Total with data at 12-month follow-up, n (%) | Durably suppressed at 12-month follow-up, n (%) | Total with data at18-month follow-up, n (%) | Durably suppressed at 18-Month follow-up, n (%) | ||||||
|
| |||||||||
| Total Sample | 99 | 99 (100.00) | 47 (47.47) | Z=−0.90 | .368 | 73 (73.74) | 39 (53.42) | Z=0.24 | .808 |
| Recruitment Location | |||||||||
| Sexual Health Clinic | 36 | 36 (100.00) | 26 (72.22) | Z=2.43 | .015 | 31 (86.11) | 23 (74.19) | Z=2.47 | .013 |
| Detoxification Center | 63 | 63 (100.00) | 21 (33.33) | Z=−2.97 | .003 | 42 (66.67) | 16 (38.10) | Z=−1.80 | .071 |
| New Yorkers Newly Diagnosed with HIV, 2014–2017 c | 8438 | 8438 (100.00) | 4339 (51.42) | Z=−1.07 | .283 | 6803 (80.62) | 3699 (54.37) | Z=3.92 | <.001 |
a
Durable viral suppression = two consecutive viral load tests at least 90 days apart, of ≤ 200 copies/mL, with no intervening unsuppressed viral load tests
b
P-value from One-Sample Proportion Test of Suppression Rate vs. 52%
c
Includes all new HIV diagnoses at a New York City provider from January 1, 2014 through December 31, 2017 that were reported to the HIV Surveillance Registry and living in NYC at the time of diagnosis, excluding participants in the current study